EMEA-000637-PIP02-10-M06

Key facts

Invented name
Fosrenol and associated names
Active substance
Lanthanum carbonate hydrate
Therapeutic area
Uro-nephrology
Decision number
P/0303/2018
PIP number
EMEA-000637-PIP02-10-M06
Pharmaceutical form(s)
  • Chewable tablets
  • Oral powder
Condition(s) / indication(s)
Treatment of hyperphosphataemia
Route(s) of administration
Oral use
Contact for public enquiries
Shire Pharmaceutical Contracts Ltd
United Kingdom
Tel. +44 (0)1423 850717
E-mail: medinfoemea@shire.com 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating